期刊文献+

肝移植治疗家族性淀粉样变多发性神经病 被引量:1

下载PDF
导出
摘要 家族性淀粉样变多发性神经病(familial amyloid polyneuropathy,FAP)为一罕见型常染色体显性遗传疾病,与转甲蛋白(transthyretin,TrR)基因的80多个位点突变相关。临床上以进行性的周围神经、自主神经病变及不同程度的内脏器官淀粉样蛋白质沉积为特征。FAP的病理基础即是转甲蛋白变异和广泛沉积。循环中95%以上的转甲蛋白由肝脏合成,其余由脉络丛和视网膜产生。原位肝移植(orthotopic liver transplantation,OLT)可消除肝脏来源的变异转甲蛋白淀粉样沉积物。这项治疗方法初始于1990年,
出处 《中国现代神经疾病杂志》 CAS 2006年第1期62-64,共3页 Chinese Journal of Contemporary Neurology and Neurosurgery
  • 相关文献

参考文献30

  • 1[1]Holmgren G,Ericzon BG,Groth CG,et al.Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.Lancet,1993,341:1113-1116.
  • 2[2]Ericzon BG,Larsson M,Herlenius G,et al.Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)and the Domino Liver Transplant Registry (DLTR).Amyloid,2003,10 (Suppl 1):67-76.
  • 3[3]Herlenius G,Wilczek HE,Larsson M,et al.Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy:results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.Transplantation,2004,77:64-71.
  • 4[4]Pomfret EA,Lewis WD,Jenkins RL,et al.Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy.Transplantation,1998,65:918-925.
  • 5[5]Bergethon PR,Sabin TD,Lewis D,et al.Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.Neurology,1996,47:944-951.
  • 6[6]Jonsen E,Suhr OB,Tashima K,et al.Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life.Amyloid,2001,8:52-57.
  • 7[7]Suhr OB.Impact of liver transplantation on familial amyloidotic polynuropathy (FAP) patients' symptoms and complications.Amyloid,2003,10 (Suppl 1):77-83.
  • 8[8]Adams D,Samuel D,Goulon-Goeau C,et al.The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.Brain,2000,123:1495-1504.
  • 9[9]Garcia-Herola A,Prieto M,Pascual S,et al.Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77transthyretin variant.Liver Transpl Surg,1999,5:246-248.
  • 10[10]Stangou AJ,Hawkins PN,Heaton ND,et al.Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy:implications for amyloid fibrillogenesis.Transplantation,1998,66:229-233.

同被引文献13

  • 1刘育平,崔亮,林丹丹,李欣茹.家族遗传性淀粉样变周围神经病超声心动图表现一例[J].中华医学超声杂志(电子版),2006,3(6). 被引量:1
  • 2刘炜霖.神经遗传学[M].3版.北京:人民卫生出版社,2011:97.99.
  • 3Arseque11 G,Planas A. Methods to evaluate the inhibition of TYR fibrillogenesis induced by small ligands [J]. Curr Med Chem, 2012,19 (15) : 2343-2355.
  • 4David A. Recent advances in the treatment of familial amyloid polyneuropathy[J].Ther Adv Neurol Disord,2013,6(2) : 129-139.
  • 5Juris JL,Lucy Qz, Merrill DB. Progression of transthyretin amy- loid neuropathy after liver transplantation [J ]. Neurology,2010, 75(4) :324-327.
  • 6Herlenius G,Wilczek HE,Larsson M,et aLTen years of inter- national experience with liver transplantation for familial amy- loidotic polyneuropathy:results from the Familial Amyloidotic Polyneuropathy World Transplant Registry[J]. Transplantation, 2004,77( 1 ) :64-71.
  • 7杜倩,王文,周颖,等.他克莫司二联与三联用药对肝移植术后患者有效性和安全性的Meta分析[J].中国医院用药评价与分析.2009.9(1):67-69.
  • 8路福顺.家族性淀粉样变性的肝移植疗法[J].日本医学介绍,1997,18(12):559-559. 被引量:1
  • 9哈肖别克.卡斯木,Bogeran.Ericssion.肝移植治疗家族性淀粉样变多神经病的临床病例分析[J].新疆医科大学学报,2008,31(9):1237-1240. 被引量:1
  • 10芦芳,朱焕改,尹自芳,周敏新,孙静.43例肝移植患者用药的护理管理[J].中华护理杂志,2009,44(4):312-314. 被引量:10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部